Charalampos S. Floudas

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.518Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae018

Top 37%

0.518DataRank

Top 37%13 citations

Fatima Karzai, Ryan David Nipp, Abdul Rafeh Naqash, James L. Gulley, Charalampos S. Floudas +1 more

Papers

Driven by 29 papers — median percentile 63. Top paper: “Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer”.

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003238

N/A

1.2DataRank · unranked

41 citations

Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai, Angie Schwab +16 more

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyac244

N/A

0.588DataRank · unranked

16 citations

Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić +14 more

Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae018

Top 37%

0.518DataRank

Top 37%13 citations

Fatima Karzai, Ryan David Nipp, Abdul Rafeh Naqash, James L. Gulley, Charalampos S. Floudas +1 more

An automated pheochromocytoma and paraganglioma lesion segmentation AI-model at whole-body 68Ga- DOTATATE PET/CT

EJNMMI Research(2024)10.1186/s13550-024-01168-5

N/A

0.390DataRank · unranked

7 citations

Jorge A. Carrasquillo, Evrim Türkbey, Esther Mena, Liza Lindenberg, Philip Eclarinal +7 more

Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection

The Oncologist(2025)10.1093/oncolo/oyaf006

N/A

0.251DataRank · unranked

4 citations

Renee N. Donahue, Seth J Steinberg, Jennifer L. Marté, Lisa M. Cordes, Charalampos S. Floudas +7 more

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

Head & Neck(2025)10.1002/hed.70076

N/A

0.104DataRank · unranked

1 citations

Tolulope Adeyelu, Harris B. Krause, Andrew Elliott, Ranee Mehra, Heloisa P. Soares +8 more

Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2518

N/A

0DataRank · unranked

11 citations

Charalampos S. Floudas, Danielle M. Pastor, Michell Manu, Elizabeth Lamping, Deneise C Francis +11 more

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.127

N/A

0DataRank · unranked

4 citations

Ravi A. Madan, Nicole J. Toney, Renee N. Donahue, Margaret E. Gatti‐Mays, Julius Strauss +12 more

Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.093

N/A

0DataRank · unranked

4 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17033

N/A

0DataRank · unranked

3 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Applications of large language models in cancer care: current evidence and future perspectives

Frontiers in Oncology(2023)10.3389/fonc.2023.1268915

N/A

0DataRank · unranked

114 citations

Dara Bracken‐Clarke, Charalampos S. Floudas, Mario Roselli, James L. Gulley, Fatima Karzai +1 more

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials

Cancer Treatment Reviews(2023)10.1016/j.ctrv.2023.102623

N/A

0DataRank · unranked

37 citations

Elias Chandran, Charalampos S. Floudas, Hyoyoung Choo‐Wosoba, Gisela Butera, Mario Roselli +3 more

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007440

N/A

0DataRank · unranked

14 citations

Charalampos S. Floudas, Asaf Maoz, Abdul Rafeh Naqash, Carter Norton, Aik Choon Tan +12 more

Matching Patients to Clinical Trials with Large Language Models

PubMed(2023)10.48550/arxiv.2307.15051

N/A

0DataRank · unranked

42 citations

Zifeng Wang, Charalampos S. Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken‐Clarke +5 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

medRxiv(2023)10.1101/2023.10.31.23297825

N/A

0DataRank · unranked

9 citations

Dara Bracken‐Clarke, Fatima Karzai, Hyoyoung Choo‐Wosoba, James L. Gulley, Charalampos S. Floudas +1 more

Phase II evaluation of combination immunotherapy with CV301, N-803, bintrafusp alfa, and M9241 in patients with advanced small bowel and colorectal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.116

N/A

0DataRank · unranked

4 citations

Jason M. Redman, Charalampos S. Floudas, Elizabeth Lamping, Deneise C Francis, Lisa M. Cordes +5 more

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps6116

N/A

0DataRank · unranked

1 citations

Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, Jenn Marte +7 more

Matching patients to clinical trials with large language models

Nature Communications(2024)10.1038/s41467-024-53081-z

N/A

0DataRank · unranked

213 citations

Zifeng Wang, Charalampos S. Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken‐Clarke +5 more

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

The Oncologist(2024)10.1093/oncolo/oyae009

N/A

0DataRank · unranked

40 citations

Dara Bracken‐Clarke, Fatima Karzai, Hyoyoung Choo‐Wosoba, James L. Gulley, Charalampos S. Floudas +1 more

Spatial Transcriptomic Analysis of Pituitary Corticotroph Tumors

Journal of the Endocrine Society(2024)10.1210/jendso/bvae064

N/A

0DataRank · unranked

4 citations

Fábio R. Faucz, Cameron Padilla, Charalampos S. Floudas, Prashant Chittiboina, Martha Quezado +2 more

Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2530

N/A

0DataRank · unranked

2 citations

Massimo Fantini, Kwong Y. Tsang, Kevin C. Conlon, Charalampos S. Floudas, Azam Ghafoor +8 more

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

European Journal of Cancer(2025)10.1016/j.ejca.2025.115589

N/A

0DataRank · unranked

6 citations

Charalampos S. Floudas, Marco Filetti, Tommaso Giovagnoli, Stefano Sganga, Antonio Vitale +13 more

In vivo CRISPR screening identifies NF1/RASA1/TP53 co-mutations and downstream MEK signaling as a common key mechanism of sinonasal tumorigenesis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.19.654661

N/A

0DataRank · unranked

0 citations

Sreenivasulu Gunti, Ramya Viswanathan, Anjali Nandal, Riley Larkin, Sung‐Woo Cho +21 more

Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2501

N/A

0DataRank · unranked

20 citations

Charalampos S. Floudas, Houssein Abdul Sater, Michell Manu, Elizabeth Lamping, Deneise C Francis +15 more

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5096

N/A

0DataRank · unranked

3 citations

Marijo Bilušić, Fatima Karzai, Lisa M. Cordes, Julius Strauss, Houssein Abdul Sater +10 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2617

N/A

0DataRank · unranked

0 citations

Katherine Lee-Wisdom, Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Claudia Palena +14 more

Charalampos S. Floudas

Indexed papers

Top data-sharing exemplar

Papers